why choose us

First received: January 29, 2023

Clinical Trial: Pharmacokinetic, Safety and Immunogenicity Study of CMAB015 and Cosentyx in Healthy Volunteers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Psoriasis

Study Type: INTERVENTIONAL


Official Title: Phase I Comparison of Pharmacokinetics, Safety, and Immunogenicity of CMAB015 Injection and Cosentyx in a Randomized, Double-blind, Parallel Controlled, Single-dose Study in Healthy Chinese Male Subje

Brief Summary: This is a randomized, double-blinded, controlled Phase I study of CMAB015 administered by subcutaneous injection.This study will characterize the pharmacokinetic, safety and immunogenicity of CMAB015 versus Cosentyx?Secukinumab ? in healthy male subjects after a single dose.

Read more